ENGlobal Corp
OTC:ENGCQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ENGlobal Corp
OTC:ENGCQ
|
US |
|
Invitro International
OTC:IVRO
|
US |
|
J
|
Japan Medical Dynamic Marketing Inc
F:JMD
|
JP |
|
Deepmarkit Corp
F:DEP0
|
CA |
|
VIA Holdings Inc
TSE:7918
|
JP |
|
S
|
Superior Gold Inc
F:G0D
|
CA |
|
Onxeo SA
F:C4X
|
FR |
|
E
|
Erytech Pharma SA
PAR:ERYP
|
FR |
|
Platinex Inc
F:9PX
|
CA |
|
E
|
Erbud SA
F:9DP
|
PL |
|
Destiny Media Technologies Inc
F:DME1
|
CA |
|
C
|
CopperCorp Resources Inc
F:NU0
|
CA |
|
M
|
Medcolcanna Organics Inc
F:MO2
|
CA |
|
Y
|
Yung Zip Chemical Ind Co Ltd
TPEX:4102
|
TW |
|
L
|
Lionhead Technology Development Co Ltd
SSE:600539
|
CN |
|
Quest Patent Research Corp
OTC:QPRC
|
US |
|
Advanced Energy Minerals Ltd
ASX:AEM
|
AU |
|
H
|
Hoshizaki Corp
OTC:HSHZY
|
JP |
|
Desktop Metal Inc
F:844
|
US |
|
Capital & Regional PLC
F:XC2R
|
UK |
|
S
|
Sirtec International Co Ltd
TPEX:5356
|
TW |
|
Asian Citrus Holdings Ltd
F:A2S
|
HK |
|
Austin Engineering Ltd
F:RZA
|
AU |
|
P
|
Proto Script Pharmaceutical Corp
OTC:PSCR
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ENGCQ's stock price target?
Not Available
ENGCQ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for ENGlobal Corp?
Projected CAGR
694%
Over the last 8 years, the compound annual growth rate for Revenue has been -9%. The projected CAGR for the next 1 year is 694%.